Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,982 | Dovepress* | 10,864+ | 1,851 | 12,715 | |
PubMed Central* | 1,118 | 322 | 1,440 | ||
Totals | 11,982 | 2,173 | 14,155 | ||
*Since 4 October 2012 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 0 | 4 |
View citations on PubMed Central and Google Scholar